Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

FHA (Functional Hypothalamic Amenorrhea): full-pipeline trial registry

2 of 2 indexed FHA (Functional Hypothalamic Amenorrhea) trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

FHA (Functional Hypothalamic Amenorrhea): 2 US clinical trials tracked, 2 recruiting.

FHA (Functional Hypothalamic Amenorrhea) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Virginia, running 1 of these trials.

Enrollment posture brief

Registry condition fha-functional-hypothalamic-amenorrhea

OPEN 2 | RECR 100% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

FHA (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near FHA (Functional Hypothalamic Amenorrhea)

FHA (Functional Hypothalamic Amenorrhea) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for FHA (Functional Hypothalamic Amenorrhea) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. FHA (Functional Hypothalamic Amenorrhea) is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on FHA (Functional Hypothalamic Amenorrhea) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

transdermal EE+LNG Drug
1 trials
oral 17β-E2 with cyclic progestin Drug
1 trials
transdermal 17β-E2 with cyclic progestin Drug
1 trials
Zoledronic acid Drug
1 trials
Romosozumab Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on FHA (Functional Hypothalamic Amenorrhea) trials. A trial with sites in several states counts in each.

Virginia 2 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this FHA (Functional Hypothalamic Amenorrhea) page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 FHA (Functional Hypothalamic Amenorrhea) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Virginia sponsors the most FHA (Functional Hypothalamic Amenorrhea) trials on record, review their full trial history before evaluating a specific study. See University of Virginia's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This FHA (Functional Hypothalamic Amenorrhea) condition card totals 2 registered trials; most-linked intervention transdermal EE+LNG; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.